Literature DB >> 24238051

Ten percent tall cells confer the aggressive features of the tall cell variant of papillary thyroid carcinoma.

Toni Beninato1, Theresa Scognamiglio, David A Kleiman, Alessia Uccelli, Daniela Vaca, Thomas J Fahey, Rasa Zarnegar.   

Abstract

BACKGROUND: The tall cell (TC) variant of papillary thyroid carcinoma (PTC) is more aggressive than classic PTC, but the percentage of TC necessary to diagnose this variant has been debated. We aimed to better determine what percentage of TC correlates with a more aggressive phenotype.
METHODS: Cases from 2005 to 2010 that were the TC variant of PTC or PTC with TC features were identified and compared with classic PTCs. All cases were reviewed to determine what percent, if any, of the tumors consisted of TC.
RESULTS: One hundred forty-one cases of PTC were reviewed. Eighty-three cases had some TC component, and 58 cases had none. There were no differences in patient demographics. Tumors with ≥10% TC had more extrathyroidal extension, angiolymphatic invasion, positive surgical margin, and lymph node involvement than classic PTC. There were more recurrences in patients with ≥10% TC, but this was not significant. Similar findings were also observed with increasing percentages of TC.
CONCLUSION: The aggressive features conferred by the presence of TC in PTCs occur with as little as 10% TC and are maintained with increasing percentages. Therefore, TC in a PTC should be reported if they comprise at least 10% of the tumor.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24238051     DOI: 10.1016/j.surg.2013.05.009

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  11 in total

Review 1.  Clinically Relevant Prognostic Parameters in Differentiated Thyroid Carcinoma.

Authors:  Tyler Janovitz; Justine A Barletta
Journal:  Endocr Pathol       Date:  2018-12       Impact factor: 3.943

2.  Prognostic Significance of the Proportion of Tall Cell Components in Papillary Thyroid Carcinoma.

Authors:  Yasuhiro Ito; Mitsuyoshi Hirokawa; Akira Miyauchi; Takuya Higashiyama; Minoru Kihara; Akihiro Miya
Journal:  World J Surg       Date:  2017-03       Impact factor: 3.352

3.  Comparison of the clinicopathological features and oncologic outcomes of the classic papillary thyroid carcinoma with tall cell features and tall cell variant.

Authors:  Kwangsoon Kim; Chan Kwon Jung; Dong-Jun Lim; Ja Seong Bae; Jeong Soo Kim
Journal:  Gland Surg       Date:  2022-01

4.  Less is More: The Impact of Multidisciplinary Thyroid Conference on the Treatment of Well-Differentiated Thyroid Carcinoma.

Authors:  Maureen D Moore; Emily Postma; Katherine D Gray; Timothy M Ullmann; James R Hurley; Stanley Goldsmith; Vivian R Sobel; Aaron Schulman; Theresa Scognamiglio; Paul J Christos; Erin Hassett; Jessica Luick; Dana Whitehall; Rasa Zarnegar; Thomas J Fahey
Journal:  World J Surg       Date:  2018-02       Impact factor: 3.352

Review 5.  A comparison of the clinicopathological features and prognoses of the classical and the tall cell variant of papillary thyroid cancer: a meta-analysis.

Authors:  Zeming Liu; Wen Zeng; Tianwen Chen; Yawen Guo; Chao Zhang; Chunping Liu; Tao Huang
Journal:  Oncotarget       Date:  2017-01-24

6.  Classic papillary thyroid carcinoma with tall cell features and tall cell variant have similar clinicopathologic features.

Authors:  Woo Jin Oh; Young Sub Lee; Uiju Cho; Ja Seong Bae; Sohee Lee; Min Hee Kim; Dong Jun Lim; Gyeong Sin Park; Youn Soo Lee; Chan Kwon Jung
Journal:  Korean J Pathol       Date:  2014-06-26

7.  Differences in miRNA and mRNA Profile of Papillary Thyroid Cancer Variants.

Authors:  Tomasz Stokowy; Danuta Gawel; Bartosz Wojtas
Journal:  Int J Endocrinol       Date:  2016-08-30       Impact factor: 3.257

Review 8.  Tall cell variant of papillary thyroid carcinoma: current evidence on clinicopathologic features and molecular biology.

Authors:  Xiaofei Wang; Wenli Cheng; Chongqing Liu; Jingdong Li
Journal:  Oncotarget       Date:  2016-06-28

Review 9.  Papillary thyroid carcinoma with tall cell features is as aggressive as tall cell variant: a meta-analysis.

Authors:  Huy Gia Vuong; Nguyen Phuoc Long; Nguyen Hoang Anh; Tran Diem Nghi; Mai Van Hieu; Le Phi Hung; Tadao Nakazawa; Ryohei Katoh; Tetsuo Kondo
Journal:  Endocr Connect       Date:  2018-12-01       Impact factor: 3.335

Review 10.  Papillary Thyroid Cancer-Aggressive Variants and Impact on Management: A Narrative Review.

Authors:  Andrés Coca-Pelaz; Jatin P Shah; Juan C Hernandez-Prera; Ronald A Ghossein; Juan P Rodrigo; Dana M Hartl; Kerry D Olsen; Ashok R Shaha; Mark Zafereo; Carlos Suarez; Iain J Nixon; Gregory W Randolph; Antti A Mäkitie; Luiz P Kowalski; Vincent Vander Poorten; Alvaro Sanabria; Orlando Guntinas-Lichius; Ricard Simo; Peter Zbären; Peter Angelos; Avi Khafif; Alessandra Rinaldo; Alfio Ferlito
Journal:  Adv Ther       Date:  2020-06-01       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.